September 10, 2015

The acquisition of Diplomat's compounding pharmacy assets by Restore Health enables Diplomat to continue their singular focus on specialty pharmacy, the companies stated. 

August 21, 2015

Diplomat Pharmacy’s summer internship and fellowship program saw 10 fellows and 25 interns spend 12 weeks gaining hands-on experience in different departments of the specialty pharmacy. 

August 14, 2015

Keveyis is the first medicine approved by the FDA for the treatment of primary periodic paralysis, which is estimated to affect approximately 5,000 people in the United States.

August 11, 2015

Iressa is a once-daily oral medication that targets and blocks the activity of epidermal growth factor receptor-tyrosine kinase.

August 4, 2015

As much as $91 million of revenue from new drugs helped drive a 49% increase in sales and a 19% increase in prescriptions dispensed through Diplomat. 

June 22, 2015

Diplomat Pharmacy announced Friday that it had acquired the Pennsylvania-based Burman’s Specialty Pharmacy, which will expand Diplomat’s hepatitis C specialty services. 

June 12, 2015

Through ACAP, Diplomat gains access to  13 million lives in Medicaid, Medicare, CHIP and other public programs.

May 12, 2015

Total prescriptions dispensed by Diplomat Pharmacy were up 6% to 194,000 in the first quarter.

April 17, 2015

Diplomat Pharmacy on Thursday named a long-time data security veteran to the chief information security officer post. 

April 3, 2015

Diplomat Pharmacy on Friday celebrated 40 years of service. 

March 24, 2015

Diplomat Pharmacy commences follow-on public offering of 7.4 million shares of its common stock.

March 16, 2015

Diplomat Pharmacy is looking to raise $200 million with a proposed follow-on public offering of its common stock.

February 26, 2015

Diplomat Pharmacy on Thursday acquired the specialty pharmacy BioRx.

 

February 25, 2015

Diplomat Pharmacy to dispense new multiple myeloma treatment from Novartis. 

February 3, 2015

Diplomat Pharmacy announced Monday that it has earned the Verified Internet Pharmacy Practice Sites seal of approval from the National Association of Boards of Pharmacy.

January 30, 2015

Diplomat Pharmacy announced Thursday that the Food and Drug Administration has approved an expanded indication of Imbruvica (ibrutinib) for the treatment of Waldenström’s macroglobulinemia (WM).

January 20, 2015

Diplomat Pharmacy on Tuesday announced the addition of Susan Faust to their senior leadership team as VP specialty infusion and market development.

December 23, 2014

Specialty pharmacy Diplomat Pharmacy has announced that it will stock Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets; dasabuvir tablets), which was approved Dec. 19 by the Food and Drug Administration.

December 4, 2014

Diplomat Pharmacy announced Wednesday that it has been selected to Pfizer's limited-distribution panel for Xalkori, Bosulif, Inlyta and Sutent.

November 6, 2014

Diplomat Pharmacy on Wednesday announced the addition of Martino Luu to their senior leadership team as VP innovation and process improvement.

 

October 10, 2014

Shares of Diplomat Pharmacy officially began trading on Friday at a price that had reached more than $17 per share in mid-afternoon trading.

 

September 29, 2014

Diplomat Pharmacy on Monday announced that it has commenced its initial public offering of 13.3 million shares of its common stock.

 

July 3, 2014

Diplomat Pharmacy on Thursday announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock.

May 5, 2014

Kmart Pharmacy has announced that it is working with Diplomat Specialty Pharmacy to give Kmart customers and Shop Your Way members access to specialty medications.